Company Description
Paranovus Entertainment Technology Ltd. engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally.
The company's product category includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids.
It also offers product marketing and e-commerce agency operation services under the Happy Buy platform to small and middle size businesses; and e-commerce solutions, internet information, and advertising services to the online stores or manufactures.
In addition, the company provides secure transaction environment, automobile procurement, and financial services for automobile manufacturers under the Taochejun automobile sales platform.
It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand.
The company was formerly known as Happiness Development Group Limited and changed its name to Paranovus Entertainment Technology Ltd. in March 2023.
The company was founded in 2004 and is headquartered in Nanping, the People's Republic of China.
| Country | China |
| Founded | 2004 |
| IPO Date | Oct 25, 2019 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 80 |
| CEO | Xuezhu Wang |
Contact Details
Address: No. 11, Dongjiao East Road, Shuangxi, Shunchang Nanping, F4 353001 China | |
| Phone | 86-0599-782-8808 |
| Website | happ.org.cn |
Stock Details
| Ticker Symbol | PAVS |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| IPO Price | $5.50 |
| CIK Code | 0001751876 |
| ISIN Number | KYG4289N2050 |
| SIC Code | 7374 |
Key Executives
| Name | Position |
|---|---|
| Xuezhu Wang | Chairman and Chief Executive Officer |
| Ye Tao CFA | Chief Financial Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 14, 2024 | 6-K | Report of foreign issuer |
| Jan 23, 2024 | 6-K | Report of foreign issuer |
| Jan 12, 2024 | 6-K | Report of foreign issuer |
| Dec 5, 2023 | 6-K | Report of foreign issuer |
| Dec 4, 2023 | EFFECT | Notice of Effectiveness |
| Nov 16, 2023 | F-3 | Filing |
| Nov 15, 2023 | 6-K | Report of foreign issuer |
| Oct 13, 2023 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Oct 13, 2023 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Sep 27, 2023 | 20-F/A | Filing |